Growth Metrics

Resmed (RMD) Total Liabilities (2016 - 2025)

Resmed's Total Liabilities history spans 16 years, with the latest figure at $2.2 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 15.58% year-over-year to $2.2 billion; the TTM value through Dec 2025 reached $2.2 billion, up 15.58%, while the annual FY2025 figure was $2.2 billion, 9.87% up from the prior year.
  • Total Liabilities reached $2.2 billion in Q4 2025 per RMD's latest filing, roughly flat from $2.2 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $2.9 billion in Q4 2022 to a low of $1.6 billion in Q4 2021.
  • Average Total Liabilities over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2024.
  • Peak YoY movement for Total Liabilities: soared 84.91% in 2022, then fell 23.4% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $1.6 billion in 2021, then skyrocketed by 84.91% to $2.9 billion in 2022, then dropped by 17.52% to $2.4 billion in 2023, then dropped by 22.07% to $1.9 billion in 2024, then increased by 15.58% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for RMD's Total Liabilities are $2.2 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.2 billion (Q2 2025).